You say:
"I think the Chinese market may have assumed that RVX would be sold by Hepalink within the next few months at a handsome valuation...and that may have supported the high EV."
I would think that HL intended to manufacture apabetalone and not sell their equity position to help bring their financials in order.
IMO....Koo